HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough head & neck cancers: trial tests smart drug timing
Disease control Recruiting nowThis study is testing a new combination of drugs given before surgery for people with advanced head and neck cancer. The goal is to see if adding a specific immune-modulating drug (a JAK1 inhibitor) to standard immunotherapy and chemotherapy can shrink tumors more effectively. Re…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for head and neck cancer patients in experimental drug trial
Disease control Recruiting nowThis study is testing whether adding an experimental drug called VS-101 to standard chemoradiation treatment works better for adults with head and neck cancer. It will involve about 30 participants to see if the combination helps control the cancer longer and is safe. The main go…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New cancer drug SH009 begins first human testing
Disease control Recruiting nowThis is an early safety study testing an experimental drug called SH009 injection in adults with advanced solid tumors who have run out of standard treatment options. The study aims to find a safe dose, see how the body processes the drug, and check for early signs that it might …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Shorter radiation course tested for aggressive skin cancer
Disease control Recruiting nowThis study is testing if a shorter, more focused radiation treatment (5 sessions) works as well as the standard longer course (20-30 sessions) for people with a serious type of skin cancer in the head and neck area that has spread to lymph nodes. The goal is to see if the shorter…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC